The Charcot-Marie-Tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system

Human Molecular Genetics

Volumn 14, Issue 11, 2005, Pages 1405-1415

  Pich, Sara ^a   Bach, Daniel ^a   Briones, Paz ^b   Liesa, Marc ^a   Camps, Marta ^a   Testar, Xavier ^a   Palacín, Manuel ^a   Zorzano, Antonio ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Institut de Bioquimica Clinica Barcelona   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GENE PRODUCT; GLUCOSE; HYBRID PROTEIN; MITOCHONDRIAL PROTEIN; MITOFUSIN 2 GENE; MUTANT PROTEIN; PROTEIN OXPHOS; PYRUVIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CELL LINE; CONTROLLED STUDY; DISEASE ASSOCIATION; FATTY ACID OXIDATION; GENE EXPRESSION REGULATION; GENE MUTATION; GENE OVEREXPRESSION; GLUCOSE OXIDATION; HELA CELL; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; MUSCLE CELL; OXIDATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; PROTEIN FUNCTION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

BASE SEQUENCE; CHARCOT-MARIE-TOOTH DISEASE; DNA PRIMERS; FATTY ACIDS; GLUCOSE; HUMANS; MEMBRANE POTENTIALS; MEMBRANE PROTEINS; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; OXIDATION-REDUCTION; OXIDATIVE PHOSPHORYLATION; PYRUVIC ACID;

MAMMALIA;

EID: 20444461625     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddi149     Document Type: Article

References (43)

1. Balaban, R.S. (1990) Regulation of oxidative phosphorylation in the mammalian cell. Am. J. Physiol., 258, C377-C389.
2. Nilsson, T., Schultz, V., Berggren, P.O., Corkey, B.E. and Tornheim, K. (1996) Temporal patterns of changes in ATP/ADP ratio, glucose 6-phosphate and cytoplasmic free Ca2+ in glucose-stimulated pancreatic beta-cells. Biochem. J., 314 (Pt 1), 91-94.
3. Brand, M.D. (1997) Regulation analysis of energy metabolism. J. Exp. Biol., 200, 193-202.
4. Skulachev, V.P. (2001) Mitochondrial filaments and clusters as intracellular power-transmitting cables. Trends Biochem. Sci., 26, 23-29.
5. Hales, K.G. and Fuller, M.T. (1997) Developmentally regulated mitochondrial fusion mediated by a conserved, novel, predicted GTPase. Cell, 90, 121-129.
6. Rapaport, D., Brunner, M., Neupert, W. and Westermann, B. (1998) Fzo1p is a mitochondrial outer membrane protein essential for the biogenesis of functional mitochondria in Saccharomyces cerevisiae. J. Biol. Chem., 273, 20150-20155.
7. Hermann, G.J., Thatcher, J.W., Mills, J.P., Hales, K.G., Fuller, M.T., Nunnari, J. and Shaw, J.M. (1998) Mitochondrial fusion in yeast requires the transmembrane GTPase Fzo1p. J. Cell Biol., 143, 359-373.
8. Santel, A. and Fuller, M.T. (2001) Control of mitochondrial morphology by a human mitofusin. J. Cell Sci., 114, 867-874.
9. Santel, A., Frank, S., Gaume, B., Herrler, M., Youle, R.J. and Fuller, M.T. (2003) Mitofusin-1 protein is a generally expressed mediator of mitochondrial fusion in mammalian cells. J. Cell Sci., 116, 2763-2774.
10. Chen, H., Detmer, S.A., Ewald, A.J., Griffin, E.E., Fraser, S.E. and Chan, D.C. (2003) Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J. Cell Biol., 160, 189-200.
11. Bach, D., Pich, S., Soriano, F.X., Vega, N., Baumgartner, B., Oriola, J., Daugaard, J.R., Lloberas, J., Camps, M., Zierath, J.R. et al. (2003) Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity. J. Biol. Chem., 278, 17190-17197.
12. Rojo, M., Legros, F., Chateau, D. and Lombes, A. (2002) Membrane topology and mitochondrial targeting of mitofusins, ubiquitous mammalian homologs of the transmembrane GTPase Fzo. J. Cell Sci., 115, 1663-1674.
13. Chen, K.H., Guo, X., Ma, D., Goo, Y., Li, Q., Yang, D., Li, P., Qiu, X., Wen, S., Xiao, R.P. and Tang, J. (2004) Dysregulation of HSG triggers vascular proliferative disorders. Nat. Cell Biol., 6, 872-883.
14. Zuchner, S., Mersiyanova, I.V., Muglia, M., Bissar-Tadmouri, N., Rochelle, J., Dadali, E.L., Zappia, M., Nelis, E., Patitucci, A., Senderek, J. et al. (2004) Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat. Genet., 36, 449-451.
15. Pareyson, D. (1999) Charcot-Marie-Tooth disease and related neuropathies: molecular basis for distinction and diagnosis. Muscle Nerve, 22, 1498-1509.
16. Shy, M.E., Garbern, J.Y. and Kamholz, J. (2002) Hereditary motor and sensory neuropathies: a biological perspective. Lancet Neurol., 1, 110-118.
17. Gemignani, F. and Marbini, A. (2001) Charcot-Marie-Tooth disease (CMT): distinctive phenotypic and genotypic features in CMT type 2. J. Neurol. Sci., 184, 1-9.
18. Koshiba, T., Detmer, S.A., Kaiser, J.T., Chen, H., McCaffery, J.M. and Chan, D.C. (2004) Structural basis of mitochondrial tethering by mitofusin complexes. Science, 305, 858-862.
19. Sanchez-Alcazar, J.A., Schneider, E., Martinez, M.A., Carmona, P., Hernandez-Munoz, I., Siles, E., De La, T.P., Ruiz-Cabello, J., Garcia, I. and Solis-Herruzo, J.A. (2000) Tumor necrosis factor-alpha increases the steady-state reduction of cytochrome b of the mitochondrial respiratory chain in metabolically inhibited L929 cells. J. Biol. Chem., 275, 13353-13361.
20. Schon, E.A. and Manfredi, G. (2003) Neuronal degeneration and mitochondrial dysfunction. J. Clin. Invest., 111, 303-312.
21. Jacobson, J., Duchen, M.R. and Heales, S.J. (2002) Intracellular distribution of the fluorescent dye nonyl acridine orange responds to the mitochondrial membrane potential: implications for assays of cardiolipin and mitochondrial mass. J. Neurochem., 82, 224-233.
22. Puigserver, P., Wu, Z., Park, C.W., Graves, R., Wright, M. and Spiegelman, B.M. (1998) A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell, 92, 829-839.
23. Puigserver, P. and Spiegelman, B.M. (2003) Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr. Rev., 24, 78-90.
24. Knutti, D. and Kralli, A. (2001) PGC-1, a versatile coactivator. Trends Endocrinol. Metab., 12, 360-365.
25. Cruciat, C.M., Brunner, S., Baumann, F., Neupert, W. and Stuart, R.A. (2000) The cytochrome bc1 and cytochrome c oxidase complexes associate to form a single supracomplex in yeast mitochondria. J. Biol. Chem., 275, 18093-18098.
26. Schagger, H. and Pfeiffer, K. (2000) Supercomplexes in the respiratory chains of yeast and mammalian mitochondria. EMBO J., 19, 1777-1783.
27. Schagger, H., de Coo, R., Bauer, M.F., Hofmann, S., Godinot, C. and Brandt, U. (2004) Significance of respirasomes for the assembly/stability of human respiratory chain complex I. J. Biol. Chem., 279, 36349-36353.
28. Kijima, K., Numakura, C., Izumino, H., Umetsu, K., Nezu, A., Shiiki, T., Ogawa, M., Ishizaki, Y., Kitamura, T., Shozawa, Y. and Hayasaka, K. (2005) Mitochondrial GTPase mitofusin 2 mutation in Charcot-Marie-Tooth neuropathy type 2A. Hum. Genet., 116, 23-27.
29. Swerdlow, R.H., Parks, J.K., Miller, S.W., Tuttle, J.B., Trimmer, P.A., Sheehan, J.P., Bennett, J.P., Jr, Davis, R.E. and Parker, W.D., Jr (1996) Origin and functional consequences of the complex I defect in Parkinson's disease. Ann. Neurol., 40, 663-671.
30. Swerdlow, R.H., Parks, J.K., Davis, J.N., Cassarino, D.S., Trimmer, P.A., Currie, L.J., Dougherty, J., Bridges, W.S., Bennett, J.P., Jr, Wooten, G.F. and Parker, W.D. (1998) Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family. Ann. Neurol., 44, 873-881.
31. Vila, M. and Przedborski, S. (2003) Targeting programmed cell death in neurodegenerative diseases. Nat. Rev. Neurosci., 4, 365-375.
32. Casley, C.S., Land, J.M., Sharpe, M.A., Clark, J.B., Duchen, M.R. and Canevari, L. (2002) Beta-amyloid fragment 25-35 causes mitochondrial dysfunction in primary cortical neurons. Neurobiol. Dis., 10, 258-267.
33. Vinals, F., Fandos, C., Santalucia, T., Ferre, J., Testar, X., Palacin, M. and Zorzano, A. (1997) Myogenesis and MyoD down-regulate Sp1. A mechanism for the repression of GLUT1 during muscle cell differentiation. J. Biol. Chem., 272, 12913-12921.
34. Damdimopoulos, A.E., Miranda-Vizuete, A., Pelto-Huikko, M., Gustafsson, J.A. and Spyrou, G. (2002) Human mitochondrial thioredoxin. Involvement in mitochondrial membrane potential and cell death. J. Biol. Chem., 277, 33249-33257.
35. Di Lisa, F., Blank, P.S., Colonna, R., Gambassi, G., Silverman, H.S., Stern, M.D. and Hansford, R.G. (1995) Mitochondrial membrane potential in single living adult rat cardiac myocytes exposed to anoxia or metabolic inhibition. J. Physiol., 486 (Pt 1), 1-13.
36. Robinson, D.G. and Ehlers, U. (1987) Methods of Preparation for Electron Microscopy: an Introduction for the Biomedical Sciences. Springer-Verlag, Tokyo.
37. Canto, C., Suarez, E., Lizcano, J.M., Grino, E., Shepherd, P.R., Fryer, L.G., Carling, D., Bertran, J., Palacin, M., Zorzano, A. and Guma, A. (2004) Neuregulin signaling on glucose transport in muscle cells. J. Biol. Chem., 279, 12260-12268.
38. Bradford, M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
39. Gutmann, I. and Wahlefeld, A.W. (1974) In Bergmeyer, H.U. (ed.), Methods of Enzymatic Analysis. Academic Press, New York, pp. 1464-1468.
40. Fischer, J.C., Ruitenbeek, W., Berden, J.A., Trijbels, J.M., Veerkamp, J.H., Stadhouders, A.M., Sengers, R.C. and Janssen, A.J. (1985) Differential investigation of the capacity of succinate oxidation in human skeletal muscle. Clin. Chim. Acta, 153, 23-36.
41. Rustin, P., Chretien, D., Bourgeron, T., Gerard, B., Rotig, A., Saudubray, J.M. and Munnich, A. (1994) Biochemical and molecular investigations in respiratory chain deficiencies. Clin. Chim. Acta, 228, 35-51.
42. Srere, P.A. (1969) Citrate synthase: [EC 4.1.3.7. Citrate oxaloacetatelyase (CoA-acetylating)]. Methods Enzymol., 13, 3-11.
43. Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275.